ThriveAdmin

Industry-First Longitudinal Cohort Study Reports Training Devices Improved Patient Performance and Engagement

By ThriveAdmin | October 5, 2018
Posted in , , , , , , , , , , ,

Industry-First Longitudinal Cohort Study Reports Training Devices Improved Patient Performance and Engagement Study Participants Were Highly Engaged With Training Devices; Prefer Additional Training at Home ORLANDO, Fla.–(BUSINESS WIRE)–Noble, the global… Read More »

Developing Demonstrators to Increase Patient Confidence and Reduce Anxiety

By ThriveAdmin | October 4, 2018
Posted in , , , , , , , , , ,

In this article, Joe Reynolds, Research Manager at Noble, using Noble’s collaboration with BD as an example, discusses the value of demonstrators for making patients comfortable and effective with their… Read More »

Device Training and Onboarding Considerations for On-Body Delivery Systems

By ThriveAdmin | September 17, 2018
Posted in , , , ,

In this article, Joe Reynolds, Research Manager at Noble, explains how on-body injection devices have arisen from the need to develop viscous, large-volume biopharmaceutical therapies, and how Noble’s on-body training… Read More »

Injection Devices: As Self-Injection Grows, Drug Delivery Gets Smarter

By ThriveAdmin | September 7, 2018
Posted in , , , , , ,

The global injectable drug delivery market is growing around 11.8% CAGR and will soon eclipse oral delivery as the most valuable route of administration of pharmaceuticals. The market was valued… Read More »

Noble Announces Launch of AdhereIT Platform for Real-Time, Error-Correcting Self-Injection

By ThriveAdmin | July 13, 2018
Posted in , , , , , , , , , , ,

Earlier this year, Medgadget spoke with Noble International about the company’s self-injection trainers designed to mimic the patient experience with prefilled syringes and autoinjectors. During the interview, we heard about… Read More »

Can Realistic Training Devices Help Make a Blockbuster?

By ThriveAdmin | June 22, 2018
Posted in , , , , , , , , , ,

Innovation is vital for survival in the pharma industry. Although huge amounts of time, money and creativity are conventionally spent on the clinical development and commercialization of new drugs, success… Read More »